Abstract ISI
 (2024)

Real-World evidence of treatment with ocrelizumab in Chilean patients with Multiple Sclerosis 4-years follow up

Del Canto, A; Garcia, L; Aylwin, E; Jürgensen, L; Guzman I.; Gutierrez, L; Barrera A.; Cruz J.P.; Bravo, S; Pelayo C.; Leon, BS; Carcamo, C; Ciampi E.